Phathom Pharmaceuticals

Phathom Pharmaceuticals company information, Employees & Contact Information

Phathom Pharmaceuticals (Nasdaq: PHAT) is a biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. We are a team of highly driven pharmaceutical professionals who are passionate about our mission to address unmet needs for patients and improve their quality of life. By ensuring all voices are heard, holding ourselves accountable to be equitable and just, and authentically supporting the people and communities impacted by our work, we strive to create a sense of inclusion and belonging. We are looking for self-motivated, creative problem solvers who are excited by the idea of working in a fast-paced start-up environment and contributing to our growth.

Company Details

Employees
408
Founded
-
Address
100 Campus Drive,
Phone
(650) 325-5156
Email
in****@****rma.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Florham Park, New Jersey
Looking for a particular Phathom Pharmaceuticals employee's phone or email?

Phathom Pharmaceuticals Questions

News

Phathom Pharmaceuticals to Report Third Quarter 2025 - GlobeNewswire

Phathom Pharmaceuticals to Report Third Quarter 2025 GlobeNewswire

Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025 - The Manila Times

Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025 The Manila Times

Phathom Pharmaceuticals to Hold Conference Call for Q3 2025 Financial Results and Business Update on October 30 - Quiver Quantitative

Phathom Pharmaceuticals to Hold Conference Call for Q3 2025 Financial Results and Business Update on October 30 Quiver Quantitative

GI Disease Treatment Developer Phathom Pharmaceuticals Announces Key September Investor Conferences - Stock Titan

GI Disease Treatment Developer Phathom Pharmaceuticals Announces Key September Investor Conferences Stock Titan

Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants - Yahoo Finance

Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants Yahoo Finance

Phathom Pharmaceuticals to Host Conference Call for Q2 2025 Financial Results on August 7, 2025 - Quiver Quantitative

Phathom Pharmaceuticals to Host Conference Call for Q2 2025 Financial Results on August 7, 2025 Quiver Quantitative

Phathom Pharmaceuticals to Reveal Q2 2025 Performance: Key Updates on VOQUEZNA Sales Expected - Stock Titan

Phathom Pharmaceuticals to Reveal Q2 2025 Performance: Key Updates on VOQUEZNA Sales Expected Stock Titan

Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing - GlobeNewswire

Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing GlobeNewswire

Phathom Pharma Files FDA Petition to Secure 10-Year Exclusivity for VOQUEZNA Drug Portfolio - Stock Titan

Phathom Pharma Files FDA Petition to Secure 10-Year Exclusivity for VOQUEZNA Drug Portfolio Stock Titan

Phathom Pharmaceuticals Submits Citizen Petition to FDA - GlobeNewswire

Phathom Pharmaceuticals Submits Citizen Petition to FDA GlobeNewswire

Top Phathom Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant